Mankind Pharma IPO: GMP, Subscription Dates, Value Band, Itemizing; Here is All You Want To Know

Mankind Pharma, the producer of the top-selling condom model Manforce Condoms, goes to open its Rs 4,326-crore preliminary public providing (IPO) subsequent week, between April 25 and April 27. The subscription window for anchor traders will open on April 24. The Mankind Pharma IPO worth band has been mounted at Rs 1,026-1,080 per share, valuing the corporate at Rs 43,264 crore primarily based on the higher band worth. Right here’s all you must know:

Mankind Pharma IPO GMP Immediately

The gray market premium (GMP) of Mankind Pharma IPO on Wednesday stood at Rs 80. It means shares of Mankind Pharma have been buying and selling at Rs 1,160, or 7.41 per cent up over the higher worth of the IPO worth band, on the gray market (Rs 1,080 + Rs 80). This means a good itemizing for the Mankind Pharma IPO subsequent week.

Mankind Pharma IPO: Key Dates

The IPO of personal fairness agency ChrysCapital-backed Mankind Pharma might be out there for public subscription between April 25 and 27. Anchor traders might be allowed to take part a day earlier than — April 24. The share allotment will happen Might 3. Nevertheless, the shares might be listed at each the NSE and the BSE.

Mankind Pharma IPO: Value Band, Lot Dimension

The IPO, which is fully a proposal on the market (OFS) of 40.06 million fairness shares by promoters and different present shareholders, has seen its worth band mounted at Rs 1,026-1,080 per share. Within the Rs 4,326-crore IPO, a bidder might bid for no less than one lot and most 13 tons. Quite a bit could have Mankind Pharma’s 13 shares.

Mankind Pharma IPO: Quotas

The preliminary public providing could have a reservation of 35 per cent for retail traders, whereas certified institutional consumers (QIBs) will have the ability to take part in 50 per cent of the full concern measurement. Non-institutional traders (NIIs) will have the ability to take part within the remaining 15 per cent of the IPO measurement.

Mankind Pharma IPO: Who Are Promoting Shares In The OFS?

Promoters Rajeev Juneja, Ramesh Juneja and Sheetal Arora are promoting shares within the OFS, other than Cairnhill CGPE, Cairnhill CIPEF, Beige Restricted, and Hyperlink Funding Belief. For the reason that IPO is totally an OFS, the corporate won’t obtain any internet proceeds from the difficulty and the complete internet proceeds will go to the promoting shareholders.

Kotak Mahindra Capital Firm, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are the book-running lead managers to the difficulty. The fairness shares are proposed to be listed on BSE and NSE.

About Mankind Pharma

Mankind Pharma is engaged in growing, manufacturing, and advertising a various vary of pharmaceutical formulations throughout numerous acute and power therapeutic areas, in addition to a number of client healthcare merchandise.

It has established a number of differentiated manufacturers in condoms, being pregnant detection, emergency contraceptives, antacid powders, vitamin and mineral dietary supplements, and anti-acne preparation classes.

It has a pan-India advertising presence and operates 25 manufacturing amenities throughout the nation. As of December 2022, the corporate had a staff of over 600 scientists and a devoted in-house R&D centre with 4 items situated at IMT Manesar, Gurugram (Haryana) and Thane (Maharashtra).

Learn all of the Newest Enterprise Information, Tax Information and Inventory Market Updates right here